ORG Partners’s ResMed RMD Stock Holding History

ORG Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$25.7K	Buy	107 +69	+182%	+$17.6K	﹤0.01%	740
2025 Q3	$10.4K	Buy	38 +23	+153%	+$6.28K	﹤0.01%	963
2025 Q2	$3.84K	Buy	15 +10	+200%	+$2.38K	﹤0.01%	1096
2025 Q1	$1.11K	Buy	+5	New	+$1.17K	﹤0.01%	1155

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ORG Partners's RMD Position: Q4 2025 in Review

ORG Partners increased its ResMed (RMD) stake by 182% in Q4 2025, buying an estimated $17.6K and bringing the position to 107 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

ORG Partners first reported a position in RMD in Q1 2025 and has held it in 4 quarters since. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

ORG Partners held 107 shares of ResMed worth $25.7K as of Q4 2025.
ORG Partners bought 69 ResMed shares in Q4 2025, an estimated $17.6K.
ResMed made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #740 holding.
ORG Partners first reported a position in ResMed in Q1 2025 and has held it in 4 quarters since.
945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.